Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridorin in diabetic nephropathy
NCT02156843Phase 3Terminated
- Sponsor
- NephroGenex
- Start
- Jun 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of pyridorin in diabetic nephropathy (DN), sponsored by NephroGenex. Started Jun 2014; status: terminated.
02
Drugs
pyridorin
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02156843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02156843.